Electric convulsion therapy in depression: a double-blind controlled trial.

Area of Science:

• Psychiatry
• Neurology
• Clinical Psychology

Background:

• Major depressive disorder is a significant global health concern.
• Electroconvulsive therapy (ECT) is a recognized treatment for severe depression.
• The specific mechanisms and necessity of the convulsion in ECT remain areas of investigation.

Purpose of the Study:

• To evaluate the therapeutic efficacy of real versus simulated bilateral electroconvulsion therapy (ECT) in patients with primary depressive illness.
• To determine the contribution of the induced convulsion to the antidepressant effects of ECT.

Main Methods:

• A double-blind, randomized trial involving 22 patients diagnosed with primary depressive illness.
• Treatments administered twice weekly for three weeks: real bilateral ECT or simulated ECT.
• Patient outcomes assessed using psychiatrist ratings (visual analogue scale), nurse ratings (nine-point scale), and patient self-assessment (Beck Depression Inventory).

Main Results:

• Patients receiving real bilateral ECT demonstrated substantial improvement across all assessment measures (p < 0.001).
• Patients initially receiving simulated ECT showed minimal improvement.
• Upon switching to real ECT, patients who had received simulated treatment also showed significant improvement (p < 0.001 for psychiatrist, p < 0.005 for nurses and Beck Inventory).

Conclusions:

• Real bilateral electroconvulsion therapy is a highly effective treatment for severe depressive illness.
• The findings strongly suggest that the induced convulsion is a critical component of the therapeutic effect of ECT.
• Further research into the neurobiological underpinnings of ECT-induced seizures is warranted.